Generic drug sales drive Abbott revenue

Oct 21 (Reuters) - Drugmaker Abbott Laboratories Inc reported a 2 percent rise in sales, helped by higher demand for its generic drugs in emerging markets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.